We currently offer only virtual/telemedicine weight loss visits to residents of Virginia only.
Please reschedule or cancel at least 24 hours prior to the start of your appointment time. Please note that there is a $75 non-refundable fee if you reschedule or cancel less than 24 hours of your scheduled appointment time. Please note that there is a non-refundable $75 no-show fee. We require a card be kept on file at all times. Please do not hesitate to contact us for any questions or concerns.
No refunds.
Our clinic does not accept insurance because most of our services are considered not medically necessary. We also utilize therapies that may be considered off-label by the FDA and not approved by insurance. We take card payments only. You are responsible for all fees associated with services rendered.
GLP-1 medications, known as GLP-1 receptor agonists, are used in the treatment of weight loss and type 2 diabetes. They mimic the action of the natural GLP-1 hormone, stimulating insulin release, inhibiting glucagon secretion, slowing gastric emptying, and promoting a feeling of fullness. There have been some recent discoveries of GLP-1s and cardiovascular benefits. More research is being conducted.
While no substance is risk-free, these medications are safe in patients who meet criteria to take them. GLP-1 medications have been on the market since 2005.
Duration of treatment is dependent on the desire of weight one wants to lose. Patients are typically prescribed Semaglutide/Tirzepatide for three months or longer. Duration can be discussed with your provider as treatment plans vary from patient to patient. Some patients may need life-long treatment.
Semaglutide is for individuals with a body mass index (BMI) of greater than 30 or a BMI greater than 27 accompanied by medical problems such as high blood pressure, Type 2 Diabetes, or high cholesterol.
Semaglutide and Tirzepatide is not approved for those who have a past medical history or family medical history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Semaglutide and Tirzepatide is not approved for individuals with a past history of an allergic reaction to the medication or if you have a diagnosis of Type I Diabetes.
The most common side effects are nausea, vomiting, diarrhea, abdominal pain, and constipation. Rarely, a more serious complication such as pancreatitis may occur from taking these medications.
We source our medications from the highest quality sources and we provide quality care with an individualized approach. This level of quality is reflected in our pricing. Obesity comes with many challenges, and affects our wallets as well. Men and women who were obese had an extra cost burden of $6,518 and $8,365 per year respectively in expenses related to obesity and early loss of life.
Source
